Taconic Biosciences
Private Company
Funding information not available
Overview
Taconic Biosciences is a privately held, Denmark-based company that is a leading enabler of preclinical drug discovery through its specialized portfolio of genetically engineered rodent models and research services. It operates as a critical service provider to the biopharma industry, offering both off-the-shelf and custom models that help researchers validate targets and test therapeutic candidates in vivo. With a global operational footprint and a focus on model quality and standardization, the company occupies a key niche in the research tools ecosystem. Its business model is built on recurring service revenue from model licensing, breeding, and related support, rather than developing its own therapeutic pipeline.
Technology Platform
Advanced genetic engineering platform for creating and supplying genetically engineered mouse and rat models (e.g., knockouts, knock-ins, humanized models). Integrated services include model generation (custom and off-the-shelf), breeding, health monitoring, cryopreservation, and rederivation to support the entire research model lifecycle.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Taconic operates in a competitive market with major players like The Jackson Laboratory (non-profit) and Charles River Laboratories (public). It differentiates through a focused portfolio of genetically engineered models, a strong reputation for quality and standardization, and a global service footprint. Competition is based on model portfolio breadth, scientific expertise, price, and service quality.